Pregnant women's choices for preventing respiratory syncytial virus (RSV)

被引:0
|
作者
Wang, Bing [1 ,2 ,3 ]
Lassi, Zohra [4 ,5 ]
Andraweera, Prabha [1 ,2 ,3 ]
Chen, Gang [6 ]
Ong, Jason J. [7 ,8 ]
Mcmillian, Mark [1 ,2 ,3 ]
Marshall, Helen [1 ,2 ,3 ]
机构
[1] Womens & Childrens Hlth Network, Vaccinol & Immunol Res Trials Unit, 72 King William Rd, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
[4] Univ Adelaide, Robinson Res Inst, Adelaide, Australia
[5] Univ Adelaide, Fac Hlth & Med Sci, Sch Publ Hlth, Adelaide, Australia
[6] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia
[7] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[8] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England
关键词
RSV; Maternal vaccine; Vaccine attitudes; Qualitative; Vaccine promotion; VACCINATION; CHALLENGES; CHILDREN;
D O I
10.1016/j.vaccine.2025.126790
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants and can lead to severe respiratory distress, especially in very young infants. No specific treatments exist for RSV. However, new preventative strategies have become available including RSV vaccine for pregnant women and monoclonal antibody for infants. This study aimed to identify and understand barriers and facilitators to the uptake of a new RSV vaccine in pregnant women and determine their underlying choices for a maternal RSV immunisation program. Additionally, the study investigated choice for maternal vaccination or administration of a long-lasting monoclonal antibody to infants. Methods: Eligible participants were pregnant women residing in Australia and aged 18 years or older. Focus group discussions and individual online interviews were conducted and data were analysed using a thematic analysis approach. Results: A total of 34 pregnant women participated in online focus group discussions or interviews, with an average age of 34 years. The identified themes were categorised into four overarching domains: 1) motivators for vaccinating during pregnancy to safeguard their babies and prevent severe diseases, 2) barriers to vaccination including vaccine safety concerns, uncertainties regarding vaccine effectiveness, and vaccine hesitancy arising from COVID-19 vaccination experiences, 3) preferred vaccination promotion strategies, including constant reminders/prompts, personalised messages, campaign focusing on serious outcomes and using diverse/lay languages, recommendations from local obstetricians and health authorities, 4) clear vaccine recommendation policies and a preference for maternal immunisation over infant immunisation. Conclusions: The maternal RSV vaccination was generally welcomed and preferred by pregnant women in our study comparing to other strategies. Preferences for RSV program promotion included diversity in languages, "nudge" reminders, and recommendations from healthcare providers.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Burden of Human Respiratory Syncytial Virus (RSV) Infection
    Patel, Harshila
    Khoury, Hanane
    Widjojoatmodjo, Myra
    Kolte, Ida
    El Khoury, Antoine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 403 - 403
  • [22] Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
    Gatt, Dvir
    Martin, Isaac
    AlFouzan, Rawan
    Moraes, Theo J. J.
    PATHOGENS, 2023, 12 (02):
  • [23] Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
    Murray, Jackelyn
    Bergeron, Harrison C.
    Jones, Les P.
    Reener, Zachary Beau
    Martin, David E.
    Sancilio, Fred D.
    Tripp, Ralph A.
    VIRUSES-BASEL, 2022, 14 (05):
  • [24] CONTROL OF NOSOCOMIAL RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS
    HALL, CB
    GEIMAN, JM
    DOUGLAS, RG
    MEAGHER, MP
    PEDIATRIC RESEARCH, 1977, 11 (04) : 436 - 436
  • [25] THE INCREASING INCIDENCE OF RESPIRATORY SYNCYTIAL VIRUS (RSV) IN IRELAND
    Patterson, K.
    Redmond, S.
    VALUE IN HEALTH, 2023, 26 (12) : S219 - S219
  • [26] Modeling epidemics caused by respiratory syncytial virus (RSV)
    Weber, A
    Weber, M
    Milligan, P
    MATHEMATICAL BIOSCIENCES, 2001, 172 (02) : 95 - 113
  • [27] Development of respiratory syncytial virus (RSV) vaccines for infants
    Gerretsen, Hannah E.
    Sande, Charles J.
    JOURNAL OF INFECTION, 2017, 74 : S143 - S146
  • [28] Modeling household dynamics on Respiratory Syncytial Virus (RSV)
    Mahikul, Wiriya
    White, Lisa J.
    Poovorawan, Kittiyod
    Soonthornworasiri, Ngamphol
    Sukontamarn, Pataporn
    Chanthavilay, Phetsavanh
    Medleyid, Graham F.
    Pan-ngum, Wirichada
    PLOS ONE, 2019, 14 (07):
  • [29] Respiratory syncytial virus (RSV) bronchiolitis and excessive thrombocytosis
    Mammas, I.
    Koutsaftiki, C.
    Tapaki-Papadopoulou, G.
    Myriokefalitakis, N.
    ACTA PAEDIATRICA, 2010, 99 (04) : 489 - 490
  • [30] Loner airway responses to respiratory syncytial virus (RSV).
    Belenky, S
    Skoner, DP
    Gentile, DA
    Angelini, BL
    Doyle, WJ
    Fireman, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S116 - S116